Subscribe to our newsletter and stay informed

Check out our list of top companies

Check out our carefully compiled lists of the most relevant and impactful companies within their fields.

Check out our list of top unicorns

Read and learn about the biggest companies that various countries have produced, how they made it, and what the future looks like for them.
July 17, 2023

Bill & Melinda Gates Foundation fuels Belgian agritech Aphea.Bio with €70M

Belgian agritech disruptor Aphea.Bio harvests €70M in game-changing Series C funding!

Aphea.Bio, a leading player in biological product development, has secured an impressive €70 million in a Series C funding round, propelling its growth and solidifying its position as a pioneer in sustainable agriculture. The investment, driven by the European Circular Bioeconomy Fund (ECBF), underscores ECBF's commitment to fostering a healthier and more resilient food system.

Aphea.Bio, founded in 2017, the company's mission revolves around offering innovative, science-based solutions that shape the future of agriculture—solutions that are sustainable, reliable, and profitable.

With this substantial funding, Aphea.Bio is poised to accelerate its research and development efforts in biologicals, expand its market presence, and transform its product offerings into commercially viable solutions. The investment not only catapults Aphea.Bio's growth but also positions the company at the forefront of the race for cutting-edge biological agricultural products.

The funding round was oversubscribed, showcasing the tremendous interest and confidence in Aphea.Bio's vision and potential. Notable participants in the round included Innovation Industries, Korys Investments, the Bill & Melinda Gates Foundation, SFPIM, BNP Paribas Fortis, and existing shareholders. This diverse group of investors further emphasizes the wide-ranging support for Aphea.Bio's groundbreaking work in sustainable agriculture.

Aphea.Bio's commitment to innovation and progress is evident not only through its impressive financial achievements but also through its recent product launches. The company's successful introduction of ΛCTIV, a groundbreaking biostimulant seed treatment, marked its debut in the market. ΛCTIV represents the first of many revolutionary products from Aphea.Bio, with plans to unveil its first maize biostimulant in 2024 and submit its initial biofungicide for regulatory approval in the US and Europe in Q1 and Q3 of the following year, respectively.

As Aphea.Bio continues to harness its highly efficient research and development platform, bolstered by state-of-the-art in-house laboratories, the company remains dedicated to pioneering solutions that will shape the agriculture of tomorrow. Through its sustained commitment to sustainable practices, Aphea.Bio strives to forge a more resilient, efficient, and prosperous future for the global food system. Aphea.

Bio's latest funding triumph and its unwavering dedication to advancing sustainable agriculture solidify its position as an industry leader and a catalyst for positive change. With the backing of influential investors and a robust pipeline of innovative products, Aphea.Bio is well-positioned to spearhead the transformation of agriculture and foster a greener, more prosperous future for generations to

Neil Hodgson Coyle
Neil Hodgson-Coyle
Editorial chief at TechNews180
Back to top

Related articles

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram